Exelixis
EXEL
#1542
Rank
ยฃ10.94 B
Marketcap
ยฃ44.16
Share price
1.95%
Change (1 day)
59.64%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company